278 related articles for article (PubMed ID: 20095887)
1. Serum chemerin and vaspin in non-alcoholic fatty liver disease.
Kukla M; Zwirska-Korczala K; Hartleb M; Waluga M; Chwist A; Kajor M; Ciupinska-Kajor M; Berdowska A; Wozniak-Grygiel E; Buldak R
Scand J Gastroenterol; 2010; 45(2):235-42. PubMed ID: 20095887
[TBL] [Abstract][Full Text] [Related]
2. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
3. Chemerin, vaspin and insulin resistance in chronic hepatitis C.
Kukla M; Zwirska-Korczala K; Gabriel A; Waluga M; Warakomska I; Szczygiel B; Berdowska A; Mazur W; Wozniak-Grygiel E; Kryczka W
J Viral Hepat; 2010 Sep; 17(9):661-7. PubMed ID: 20002564
[TBL] [Abstract][Full Text] [Related]
4. Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress.
Farhangi MA; Alipour B; Jafarvand E; Khoshbaten M
Arch Med Res; 2014 Oct; 45(7):589-95. PubMed ID: 25450583
[TBL] [Abstract][Full Text] [Related]
5. Chemerin as a novel non-invasive serum marker of intrahepatic lipid content in obese children.
Kłusek-Oksiuta M; Bialokoz-Kalinowska I; Tarasów E; Wojtkowska M; Werpachowska I; Lebensztejn DM
Ital J Pediatr; 2014 Nov; 40():84. PubMed ID: 25399407
[TBL] [Abstract][Full Text] [Related]
6. The correlation between serum adipokines levels and metabolic indicators in girls with Turner syndrome.
Zhang Y; Chen RM; Lin XQ; Yuan X; Yang XH
Cytokine; 2019 Jan; 113():139-143. PubMed ID: 29983357
[TBL] [Abstract][Full Text] [Related]
7. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery.
Sell H; Divoux A; Poitou C; Basdevant A; Bouillot JL; Bedossa P; Tordjman J; Eckel J; Clément K
J Clin Endocrinol Metab; 2010 Jun; 95(6):2892-6. PubMed ID: 20375212
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity.
Bekaert M; Ouwens DM; Hörbelt T; Van de Velde F; Fahlbusch P; Herzfeld de Wiza D; Van Nieuwenhove Y; Calders P; Praet M; Hoorens A; Geerts A; Verhelst X; Kaufman JM; Lapauw B
Obesity (Silver Spring); 2016 Dec; 24(12):2544-2552. PubMed ID: 27768254
[TBL] [Abstract][Full Text] [Related]
9. Effects of rhythmic aerobic exercise plus core stability training on serum omentin, chemerin and vaspin levels and insulin resistance of overweight women.
Faramarzi M; Banitalebi E; Nori S; Farzin S; Taghavian Z
J Sports Med Phys Fitness; 2016 Apr; 56(4):476-82. PubMed ID: 25651894
[TBL] [Abstract][Full Text] [Related]
10. Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitis.
Genc H; Dogru T; Tapan S; Kara M; Ercin CN; Aslan F; Kantarcioglu M; Karslioglu Y; Sertoglu E; Erbil MK; Bagci S
Scand J Gastroenterol; 2011 Nov; 46(11):1355-61. PubMed ID: 21770819
[TBL] [Abstract][Full Text] [Related]
11. Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease.
Yilmaz Y; Kurt R; Gurdal A; Alahdab YO; Yonal O; Senates E; Polat N; Eren F; Imeryuz N; Oflaz H
Atherosclerosis; 2011 Jul; 217(1):125-9. PubMed ID: 21513939
[TBL] [Abstract][Full Text] [Related]
12. Relationship of serum novel adipokine chemerin levels with body composition, insulin resistance, dyslipidemia and diabesity in Saudi women.
Habib SS; Eshki A; AlTassan B; Fatani D; Helmi H; AlSaif S
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1296-1302. PubMed ID: 28387898
[TBL] [Abstract][Full Text] [Related]
13. Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome.
Guvenc Y; Var A; Goker A; Kuscu NK
J Int Med Res; 2016 Aug; 44(4):796-805. PubMed ID: 27225862
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease.
Aktas B; Yilmaz Y; Eren F; Yonal O; Kurt R; Alahdab YO; Celikel CA; Ozdogan O; Imeryuz N; Kalayci C; Avsar E
Metabolism; 2011 Apr; 60(4):544-9. PubMed ID: 20580037
[TBL] [Abstract][Full Text] [Related]
15. Comment and reply on: Serum chemerin and vaspin in non-alcoholic fatty liver disease.
Dogru T; Karadurmus N; Tapan S; Genc H
Scand J Gastroenterol; 2010 Aug; 45(7-8):1000-1; author reply 1001-2. PubMed ID: 20377484
[No Abstract] [Full Text] [Related]
16. Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis.
Pohl R; Haberl EM; Rein-Fischboeck L; Zimny S; Neumann M; Aslanidis C; Schacherer D; Krautbauer S; Eisinger K; Weiss TS; Buechler C
Eur J Clin Invest; 2017 Jan; 47(1):7-18. PubMed ID: 27797398
[TBL] [Abstract][Full Text] [Related]
17. Serum lipocalin-2, cathepsin S and chemerin levels and nonalcoholic fatty liver disease.
Ye Z; Wang S; Yang Z; He M; Zhang S; Zhang W; Wen J; Li Q; Huang Y; Wang X; Lu B; Zhang Z; Su Q; Hu R
Mol Biol Rep; 2014 Mar; 41(3):1317-23. PubMed ID: 24390241
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease.
Yilmaz Y; Yonal O; Kurt R; Alahdab YO; Eren F; Ozdogan O; Celikel CA; Imeryuz N; Kalayci C; Avsar E
Scand J Gastroenterol; 2011 Jan; 46(1):91-7. PubMed ID: 20809771
[TBL] [Abstract][Full Text] [Related]
19. Vaspin, resistin, retinol-binding protein-4, interleukin-1α and interleukin-6 in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Polymerou V; Papadimitriou KG; Zavos C; Katsinelos P
Ann Hepatol; 2016; 15(5):705-14. PubMed ID: 27493109
[TBL] [Abstract][Full Text] [Related]
20. Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus.
Zhang Z; Wang J; Wang H
Exp Ther Med; 2018 Mar; 15(3):2936-2940. PubMed ID: 29456698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
